http://www.ymabs.com
Y-mAbs Therapeutics, Inc. Company Intro
Industry
Healthcare
Y-mAbs Therapeutics, Inc. Headquaters
230 Park Avenue
New York,10169
United States
Y-mAbs Therapeutics, Inc. Share price
17 May 2023 14:08 GMT
$9.89
-0.13 (-1.3 %)
Y-mAbs Therapeutics, Inc. Market cap
$423.675 M
WMC RANKING
2024
Y-mAbs Therapeutics, Inc. # 155
BiotechnologyLatest Y-mAbs Therapeutics, Inc. News
12 Feb 2024
Y-mAbs Therapeutics (NASDAQ:YMAB) Hits New 12-Month High at $14.25
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB - Get Free Report)'s stock price reached a new 52-week high during trading on Monday . The stock traded as high as...
12 Feb 2024
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional ...
PRNewswire/ -- The "Checkpoint Inhibitors Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The latest comprehensive research...
13 Feb 2024
Repare Therapeutics Inc. (RPTX) Soars 8.8%: Is Further Upside Left in the Stock?
Repare Therapeutics Inc. (RPTX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings...
WMC Market Score
WMC Market to Revenue Score
Y-mAbs Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Y-mAbs Therapeutics, Inc. | USD | $26,133 | $145,284 | $-59,745 | $4,237M | 155 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Y-mAbs Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Y-mAbs Therapeutics, Inc. Post vs Top 4 Industry Competitors
Y-mAbs Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Y-mAbs Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Y-mAbs Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Y-mAbs Therapeutics, Inc. | 0.28 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
